Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Dasatinib in Treating Patients With Previously Treated Malignant Mesothelioma

ClinicalTrials.gov ID: NCT00509041

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00509041. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 2:55 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Study of Dasatinib (NSC #732517) in Patients With Previously Treated Malignant Mesothelioma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Dasatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. PURPOSE: This phase II trial is studying how well dasatinib works in treating patients with previously treated malignant mesothelioma.

Study identification

NCT ID
NCT00509041
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
46 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2007 (Type not available)
Primary completion
Feb 2010 (Actual)
Completion
Dec 2012 (Actual)
Last update posted
Aug 11, 2016

2007 – 2012

United States locations

U.S. sites
37
U.S. states
20
U.S. cities
32
Facility City State ZIP Site status
Rebecca and John Moores UCSD Cancer Center La Jolla California 92093-0658 —
UCSF Helen Diller Family Comprehensive Cancer Center San Francisco California 94115 —
Tunnell Cancer Center at Beebe Medical Center Lewes Delaware 19958 —
CCOP - Christiana Care Health Services Newark Delaware 19713 —
Lombardi Comprehensive Cancer Center at Georgetown University Medical Center Washington D.C. District of Columbia 20007 —
Florida Hospital Cancer Institute at Florida Hospital Orlando Orlando Florida 32803-1273 —
Curtis and Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center Savannah Georgia 31403-3089 —
University of Chicago Cancer Research Center Chicago Illinois 60637-1470 —
Elkhart General Hospital Elkhart Indiana 46515 —
Fort Wayne Medical Oncology and Hematology Fort Wayne Indiana 46845 —
Howard Community Hospital Kokomo Indiana 46904 —
Center for Cancer Therapy at LaPorte Hospital and Health Services La Porte Indiana 46350 —
CCOP - Northern Indiana CR Consortium South Bend Indiana 46601 —
Memorial Hospital of South Bend South Bend Indiana 46601 —
Saint Joseph Regional Medical Center South Bend Indiana 46617 —
South Bend Clinic South Bend Indiana 46617 —
Harry & Jeanette Weinberg Cancer Institute at Franklin Square Hospital Center Baltimore Maryland 21237 —
Union Hospital Cancer Program at Union Hospital Elkton MD Maryland 21921 —
Massachusetts General Hospital Boston Massachusetts 02114 —
Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston Massachusetts 02115 —
Lakeland Regional Cancer Care Center - St. Joseph Saint Joseph Michigan 49085 —
Masonic Cancer Center at University of Minnesota Minneapolis Minnesota 55455 —
Missouri Baptist Cancer Center St Louis Missouri 63131 —
Arch Medical Services, Incorporated at Center for Cancer Care and Research St Louis Missouri 63141 —
Methodist Estabrook Cancer Center Omaha Nebraska 68114 —
Cancer Institute of New Jersey at Cooper - Voorhees Voorhees Township New Jersey 08043 —
SUNY Upstate Medical University Hospital Syracuse New York 13210 —
Duke Comprehensive Cancer Center Durham North Carolina 27710 —
Wayne Memorial Hospital, Incorporated Goldsboro North Carolina 27534 —
Kinston Medical Specialists Kinston North Carolina 28501 —
Iredell Memorial Hospital Statesville North Carolina 28677 —
Wake Forest University Comprehensive Cancer Center Winston-Salem North Carolina 27157-1096 —
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus Ohio 43210-1240 —
CCOP - Greenville Greenville South Carolina 29615 —
Mountainview Medical Berlin Corners Vermont 05602 —
Fletcher Allen Health Care - University Health Center Campus Burlington Vermont 05401 —
Danville Regional Medical Center Danville Virginia 24541 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00509041, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 11, 2016 · Synced Nov 15, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.